Cancelled due to Corona-virus. The meeting will be postponed to next year. Already SAVE THE DATE on 23./24. April 2021!

Friday 24^th April 2020

13:45      Welcome and introduction (D. Betticher, Fribourg)

Multidisciplinary Management of Kidney Cancer (A. Mattei, M. Amram)

13:50      Local treatment of the primary tumor in the Metastatic situation in 2020 – who needs surgery? (A. Mattei, Luzern)

14:20      Systemic therapy for clear-cell mRCC (S. Aeppli, St. Gallen)

14:50      Systemic therapy for non-clear cell mRCC (M. Amram, Genève)

15:20      Case presentation by attendees/discussion

15:45      Coffee break

Management of locally advanced node positive prostate cancer (T. Hermanns, D. Zwahlen)

16:15      Surgical Approach to node positive prostate cancer (cN+) (T. Maurer, Hamburg)

16:45      Radiation therapy management of cN1 or pN1 (M0) prostate cancer (D. Zwahlen, Winterthur)

17:15      Systemic therapy for men with cN1 or pN1 prostate cancer (S. Gillessen, Bellinzona)

17:45      Case presentation by attendees/discussion

18:30      Adjourn

Saturday 25^th April 2020

Testicular Cancer (S. Gillessen, A. Hiester)

08:00      Management of Stage II seminoma (A. Papachristofilou, Basel)

08:30      Management of residual mass after primary chemo-therapy in metastatic testicular cancer (A. Hiester, Düsseldorf)

09:00      Management of intermediate and poor prognosis germ-cell carcinoma of the testis (A. Lorch, Zürich)

09:30      Case presentation by attendees/discussion

10:00      Coffee break

Urothelial carcinoma (A. Templeton, T. Hermanns)                                                                                       

10:30      Management of upper tract urothelial carcinoma (T. Hermanns, Zürich)

11:00      Management of localized muscle-invasive bladder cancer (A. Templeton, Basel)

11:30      Systemic therapy for metastatic urothelial carcinoma in 2020 (A. Omlin, St. Gallen)

12:00      Wrap up (A. Omlin, T. Hermanns, D. Zwahlen)

12:15      End

Workshop organizers:

PD Dr. Aurelius Omlin, Medical Oncology

Prof. Daniel Zwahlen, Radio-Oncology

Dr. Thomas Hermanns, Urology